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Infection of non-dividing cells is a biological property of HIV-1 crucial for virus transmission and AIDS pathogenesis.
This property depends on nuclear import of the intracellular reverse transcription and pre-integration complexes
(RTCs/PICs). To identify cellular factors involved in nuclear import of HIV-1 RTCs, cytosolic extracts were fractionated by
chromatography and import activity examined by the nuclear import assay. A near-homogeneous fraction was
obtained, which was active in inducing nuclear import of purified and labeled RTCs. The active fraction contained
tRNAs, mostly with defective 39 CCA ends. Such tRNAs promoted HIV-1 RTC nuclear import when synthesized in vitro.
Active tRNAs were incorporated into and recovered from virus particles. Mutational analyses indicated that the
anticodon loop mediated binding to the viral complex whereas the T-arm may interact with cellular factors involved in
nuclear import. These tRNA species efficiently accumulated into the nucleus on their own in a energy- and
temperature-dependent way. An HIV-1 mutant containing MLV gag did not incorporate tRNA species capable of
inducing HIV-1 RTC nuclear import and failed to infect cell cycle–arrested cells. Here we provide evidence that at least
some tRNA species can be imported into the nucleus of human cells and promote HIV-1 nuclear import.
Citation: Zaitseva L, Myers R, Fassati A (2006) tRNAs promote nuclear import of HIV-1 intracellular reverse transcription complexes. PLoS Biol 4(10): e332. DOI: 10.1371/journal.
pbio.0040332
Introduction
HIV-1 infects cells of the immune system expressing CD4,
in particular T helper lymphocytes and macrophages [1].
Studies on the acute phase of SIV (simian immunodeﬁciency
virus) and HIV infection in primate models and in patients
have indicated that infection of mucosal resting CD4
þ
memory T cells and macrophages is crucial for subsequent
viral spread and progression to AIDS [2–5]. Moreover, HIV-1
infection of microglial cells in the central nervous system is a
necessary step for the development of AIDS-related dementia
[6]. Macrophages, microglial cells, and unstimulated CD4
þ
memory T lymphocytes do not undergo mitotic division,
underscoring HIV-1 and other lentiviruses’ ability to infect
non-dividing cells [7,8].
HIV-1 infection of non-dividing cells is thus recognized as
having a fundamental role in virus transmission as well as
AIDS pathogenesis, and it has been extensively investigated.
Biochemical studies have indicated that infection of non-
dividing cells depends on active nuclear import of the
intracellular viral complex mediating reverse transcription
and integration of the viral genome (hereafter called reverse
transcription complex or RTC) [9].
Several components of the HIV-1 RTC are implicated in its
nuclear import, but little is known of the cellular pathways
involved (reviewed in [10,11]). Although the identiﬁcation of
nuclear localizing signals (NLS) within the RTC seemed the
most obvious step to understand HIV-1 nuclear import,
several limitations of this approach have now become
apparent. First, mutations of viral proteins may have
pleiotropic effects or compromise virus viability, which
confound phenotypic analysis. Second, multiple pathways
may exist for nuclear import of HIV-1 RTCs, and deletion or
mutation of one or more viral components may not result in
a detectable phenotype. Third, cellular factors present in the
RTC may also be involved [12]. Lastly, rapid virus uncoating
may be critical to let the RTC become engaged with the
cellular nuclear import machinery, since murine leukaemia
virus (MLV) capsid protein, and presumably the presence of
an intact core, has been shown to have a negative impact on
infection of non-dividing cells [13].
We have developed a different experimental approach that
primarily aims to identify the components of the cellular
machinery responsible for nuclear import of HIV-1 RTCs
[14]. This approach is based on the use of puriﬁed RTCs as
substrate in the nuclear import assay, which is well
established in the nuclear import ﬁeld and has been applied
to study nuclear import of several viruses (reviewed in [15–
17]). Brieﬂy, cells are treated with digitonin to permeabilize
selectively the plasma membrane, leaving intact the nuclear
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PLoS BIOLOGYenvelope. Cytosolic contents are washed out, and nuclear
import is reconstituted by the addition of ﬂuorescent-
labelled puriﬁed RTCs, cytosolic extracts or puriﬁed trans-
port receptors, the components of the Ran system, and an
energy-regenerating system. Nuclear accumulation of the
substrate is then analyzed by ﬂuorescence microscopy [18].
This approach circumvents several of the problems listed
above. First, it does not depend on mutations of viral
proteins, and second, putative nuclear import components
can be tested individually, thus multiple and potentially
redundant import pathways can be identiﬁed and dissected.
Using this approach we have recently found that importin
7 (imp7) is implicated in nuclear import of HIV-1 RTCs and
that siRNA-mediated depletion of imp7 inhibits HIV-1
infection [14]. However, knock down of imp7 reduces HIV-
1 infection by only a few fold, and it has been suggested that
imp7 alone may not be sufﬁcient for HIV-1 infection in
primary macrophages [19], which has led to the hypothesis
that additional factors might be involved. To identify addi-
tional pathways for HIV-1 nuclear import, we have fractio-
nated cytosolic extracts by ammonium sulphate (AS)
precipitation and chromatography and followed RTC import
activity using the nuclear import assay. The active fraction
was puriﬁed to near-homogeneity, and surprisingly, it turned
out to contain tRNAs. Such tRNAs induced HIV RTC nuclear
import, were incorporated into virus particles, and accumu-
lated into the nucleus on their own in an energy- and
temperature-dependent way.
Results
To investigate whether there are other cellular factors,
which in addition to imp7 and Ran can induce nuclear
import of HIV-1 RTCs, we have fractionated high-speed
cytosolic extracts (HSE) from HeLa cells [20] by AS
precipitation. Preliminary experiments showed that imp7
and other importins precipitated in 45% AS and Ran
precipitated in 60% AS (unpublished data). We therefore
subjected HSE to a 60% AS precipitation step and tested the
resulting pellet and supernatant in the nuclear import assay.
Although imp7 and Ran were found in the 60% AS pellet
fraction only (Figure 1A), both pellet (60P) and supernatant
(60S) from this precipitation step supported RTC nuclear
import equally well (Figure 1B). Incubating the 60P fraction
with a low-substitution Phenyl-Sepharose column, a proce-
dure that depletes all importins from HSE [21] resulted in the
loss of imp7 (Figure 1A) and RTC nuclear import activity
from the 60P fraction (Figure 1B). These results showed that
additional RTC nuclear import factors were present in HSE,
which were not precipitated in 60% AS and had properties
distinct from imp7 and other importins.
Characterization of the 60S Fraction
The 60S fraction was further fractionated by chromatog-
raphy. 60S was bound to a hydrophobic interaction column
(HIC), eluted by a 60% to 0% AS gradient, dialysed
extensively, and tested in the nuclear import assay. The
fraction with RTC import ability eluted from the column at
approximately 50% AS (unpublished data). The active
fraction from HIC was then loaded onto an ion exchange
column and eluted with a 0 to 1M NaCl gradient. Six main
fractions were obtained and analyzed by SDS-PAGE and silver
stain, and by the nuclear import assay (Figure 2A and 2B). As
shown in Figure 2B, fraction E, which eluted from the column
with 0.5 M NaCl, was the most active in inducing RTC nuclear
import in permeabilized HeLa cells. Fraction D also had
activity, but lower than fraction E. After silver stain of the
protein gel, it became apparent that fraction E contained two
main bands migrating at approximately 20 and 12 KDa
(Figure 2A). Surprisingly, the two bands had an unusual
brownish colour instead of the black typical of proteins
visualized by silver stain. The brownish colour is seen with
glycoproteins or lipoproteins, but all our attempts to detect
glycans or lipid residues were unsuccessful. Upon closer
inspection of the gel, we observed that fraction F contained a
smear of the same colour, highly suggestive of nucleic acids,
hence fraction E was digested with proteinase K or nuclease
S7, and then analyzed by SDS or native PAGE. As shown in
Figure 2C, proteinase K digested a control protein (RNAseB),
but had no effect at all on fraction E. On the other hand,
nuclease S7 digested almost completely fraction E as well as
the total RNA control. Thus fraction E contained nucleic
acids.
RNA Is the Active Component in the 60S
To ﬁnd out if nucleic acids were DNA or RNA, the active
fraction (this time obtained by 60% AS precipitation and
HIC chromatography) was digested by proteinase K and
extracted by phenol/chloroform. The resulting sample (here-
after called 60S nucleic acids, 60S NA) was ﬁrst treated with
nuclease S7 or with DNAse-free RNAse, and the nucleic acids
re-puriﬁed by treatment with proteinase K followed by
phenol/chloroform extraction and ethanol precipitation.
Samples were then analyzed by SDS-PAGE and silver stain.
As shown in Figure 3A, the 60S NA fraction contained a main
band migrating with an apparent size of approximately 80 nt,
in addition to smaller bands migrating around 40 to less than
20 nt. Both nuclease S7 and DNAse-free RNAse digested the
60S NA, suggesting that RNA was its component (Figure 3A).
The 60S fraction and the 60S NA treated with nucleases and
re-puriﬁed as described earlier were also tested in the nuclear
import assay. As shown in Figure 3B, 60S induced strong RTC
nuclear import in permeabilized primary human macro-
phages, the 60S NA fraction was also clearly active, albeit at
reduced levels, whereas the nuclease-treated 60S NA fraction
was inactive, similar to a control 21mer siRNA or total RNA.
Moreover, the 60S NA prepared from Jurkat and SupT1
lymphocytic cells was also active in inducing RTC nuclear
import, indicating that this activity was not limited to HeLa
extracts (Figure S1). We further conﬁrmed that the 60S NA
contained small RNA molecules by 39-end radiolabelling of
the samples with T4 RNA ligase and analysis by denaturing
PAGE. Figure 3C shows the resulting radiolabelled bands
ranging in size from approximately 100 to less than 20 nt.
The 60S NA Fraction Contains tRNA-Like Molecules
Figure 3C shows that the 60S NA contained several small
RNAs, and we therefore attempted to isolate and clone the
active species. The 60S NA fraction was size-fractionated by
denaturing PAGE and visualized by SYBR gold staining. Each
band was then cut, eluted from the gel and re-examined by
denaturing PAGE to conﬁrm its size and by the nuclear
import assay to conﬁrm its activity. As shown in Figure 4A,
the nine main bands present in the 60S NA were correctly
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samples was equalized prior to the nuclear import assay.
Importantly, fraction 2, migrating with an approximate size
of 80 nt, showed the highest RTC nuclear import activity
(Figure 4B). Having isolated the most active fraction, we
adapted a method described by Elbashir et al. [22] to clone it.
Brieﬂy, an adaptor was ligated to the 39 end of fraction 2, and
the sample was gel puriﬁed. All our attempts to ligate a 59-end
adaptor were unsuccessful, so the sample with the 39-end
adaptor was used as a template for ﬁrst strand cDNA
synthesis, and this was followed by addition of a polyC tail
to its 39 end by terminal transferase. The template was then
ampliﬁed by PCR (using proof-reading Taq polymerase),
cloned, and sequenced.
Of more than 100 sequences examined, 31 distinct clones
were obtained, and several of them were severely or partially
truncated, presumably due to RT pausing at hypermodiﬁed
nucleotides (Table 1). A sequence alignment of the 31 clones
indicated that they all belonged to the same family of small
RNAs, and a BLAST search of the human genome database
indicated that they were up to 97% homologous to some
human tRNAs (Table 1). In particular, of 31 clones, 11 were
highly homologous to tRNA
Gly, six to tRNA
Lys1,2, four to
tRNA
Glu, three to tRNA
Val, and two to tRNA
Ala, tRNA
Tyr, and
tRNA
Arg. We could not ﬁnd perfectly matching sequences in
Figure 1. imp7 and Additional Cytosolic Factors Support RTC Nuclear Import
(A) Western blot showing depletion of both imp7 and Ran in the supernatant (60S) of the 60% AS precipitation step and depletion of imp7 but not Ran
from the 60% AS precipitation pellet (60P) after low-substitution Phenyl-Sepharose chromatography (d60P).
(B) Nuclear import in permeabilized HeLa cells in the presence of labelled RTCs, 13energy-regenerating system and buffer (panel ctr ), 1lM imp7þ13
Ran mix (panel imp7), 0.5 mg/ml of the pellet (panel 60P) or supernatant (panel 60S) fractions from the 60% AS precipitation step, or 60P after low-
substitution Phenyl-Sepharose chromatography (panel d60P). Images were acquired by confocal microscopy using the same settings. Scale bar
indicates 25 lm.
DOI: 10.1371/journal.pbio.0040332.g001
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tRNAs Promote Nuclear Import of HIV-1Figure 2. Purification and Characterization of the Active Component in the 60S
(A) Chromatographic profile obtained after hydrophobic interaction and ion exchange chromatography of the original 60S (see Materials and Methods).
Individual fractions were analyzed by SDS-PAGE and silver staining (60S, 20-lg protein/lane, and Fractions (Fr) A to F, 10-lg protein/lane). Asterisks
indicate the two bands present in FrE.
(B) Nuclear import of YOYO-1–labelled RTCs in permeabilized HeLa cells in the presence of 13energy-regenerating system, 60S, fractions FrA to FrF (0.5
mg/ml) or buffer (ctr –).
(C) The two bands in FrE are nucleic acids. Equal amounts of FrE were subjected to proteinase K (PK) or nuclease S7 (NS7) treatment (see Materials and
Methods) and analyzed by SDS-PAGE or native PAGE followed by silver staining. Total HeLa RNA (totRNA) and RNAse B were used as controls for
nuclease or proteinase digestions, respectively.
DOI: 10.1371/journal.pbio.0040332.g002
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tRNAs Promote Nuclear Import of HIV-1the human genome database, suggesting that these small
RNAs did not represent a new class of tRNAs genes, and that
small differences were most likely due to artefacts during
reverse transcription [23]. Remarkably, all clones except two
(E1 and H1) lacked the complete 39 CCA end typical of
mature tRNAs. Moreover, compared to typical tRNAs, most
clones had the 59 end shortened by one or more nucleotides,
with the exception of clone B3 that had a longer than normal
59 end (Table 1). Presumably this is due to RT pausing during
ﬁrst strand cDNA synthesis. The tRNAscan-SE search server
(Washington University) predicted all our clones to fold into
the typical tRNA cloverleaf secondary structure, with the
exception of the truncated ones (unpublished data) [24].
To investigate which of these RNA molecules were able to
support nuclear import of HIV-1 RTCs, we have selected 14
sequences from ‘‘full length’’ clones belonging to the three
most abundant species, i.e., with homology to tRNA
Gly,
tRNA
Glu and tRNA
Lys1,2 and transcribed them in vitro from
a T7 promoter (Table 1). Since T7 polymerase can add extra
non-template nucleotides to the 39 ends of transcripts, all T7
products were carefully puriﬁed in long denaturing gels using
standards of known size, eluted, ethanol-precipitated, and
used in the nuclear import assay to test their ability to induce
RTC nuclear import. Of 14 RNAs analyzed, seven showed
good import activity (A2, A3, B4, and G1–G4), four had
intermediate activity, and three had weak activity (A9, B1, and
B2) (Figure 5A). To better quantify import activity of the
various RNA molecules, confocal images from six independ-
ent nuclear import experiments were analyzed by Meta-
Morph to calculate the mean ﬂuorescent value per cell
nucleus, an indirect measure of the efﬁciency of RTC nuclear
import (see also Figure S2). As shown in Figure 5B, all the
RNA molecules with homology to tRNA
Lys1,2 were very active
in inducing RTC nuclear import. However, only two RNAs
with homology to tRNA
Gly and one with homology to tRNA
Glu
showed a similar degree of activity. The RTC nuclear import
activity of the G3 RNA was conﬁrmed by ﬂuorescent in situ
hybridization (FISH) with a probe spanning the HIV-1 vector
genome (Figure S3). The G3 RNA was active in inducing HIV-
1 RTC, but not MLV RTC nuclear accumulation (Figure S4).
Interestingly, wild-type tRNA
Lys1,2 had low nuclear import
activity (the high standard deviation for tRNA
Lys1,2 in Figure
5B is due to nuclear import activity above background in one
out of six experiments). This could also be due to rapid
nuclear import and re-export of such tRNAs resulting in a
‘‘neutral’’ phenotype in our experimental conditions. The
Ran mix was not required for tRNA-mediated nuclear import
of RTCs (unpublished data).
To examine the speciﬁc activity of the RNA molecules
transcribed in vitro, we estimated the amount of G2/G3 RNAs
in the 60S NA fraction and in the HSE nucleic acids (NA)
preparation by Northern blot and Phosphoimager analysis
(Figure 5C) (sequence similarity prevented us from distin-
guishing between G2 and G3 RNAs). A9 tRNA (tRNA
Gly) was
used as control for speciﬁc hybridization. The G2/G3 RNAs
represented approximately 10% of total small RNA loaded on
the gel or 10 ng per 100 ng of 60S NA and HSE NA (these
fractions contained different RNA species so no accurate
value of their molarity could be obtained). Quantitative
analysis of RTC nuclear import indicated that 10ng of G3
RNA (corresponding to 14nM) had a similar or higher activity
than 100ng of 60S NA and HSE NA (Figure 5D). Moreover,
the amount of HSE sufﬁcient to support RTC nuclear
accumulation in permeabilized cells contained 80–100 ng
small RNA (unpublished data). Thus it appeared that
synthetic and endogenous tRNAs were similarly active.
Synthetic tRNAs lacked hypermodiﬁcation, hence these
results suggested that tRNA post-transcriptional modiﬁcation
may not be critical for nuclear import activity.
To investigate the speciﬁcity of tRNA-mediated RTC
nuclear import, the M9 peptide fused to the maltose binding
protein (MBP) was chosen as an alternative substrate. M9 is a
nuclear import signal for hnRNP A1 recognised by trans-
portin, and it was chosen because its mechanism of nuclear
import is mainly Ran-independent [25–27]. MBP-M9 nuclear
import was supported by transportin, but not by 60S NA,
Fraction 2, and G3 and B2 RNAs added at a concentration
sufﬁcient for maximal activity with RTC (Figure S5). Thus,
these RNA molecules were speciﬁcally inducing RTC nuclear
import.
The T- and Anticodon Arms Are Required for Nuclear
Import Activity
It was surprising to ﬁnd that wild-type tRNA
Lys1,2 appeared
to have little RTC nuclear import activity compared to our
very homologous RNA molecules, and we wondered if the
CCA end had any effect on this phenotype. A variant of the
G2 clone was generated by PCR to make it identical to the
wild-type tRNA
Lys1,2 except for the 39 CCA end, then a CCA
tail was speciﬁcally added to its 39 end. These mutant RNAs
were synthesized in vitro by T7 transcription and puriﬁed in
denaturing gels (see the supplementary materials and
methods [Protocol S1] and Tables S1 and S2). The addition
of the CCA tail was conﬁrmed by assessing size mobility in
long 15% denaturing PAGE against standards of known size
(Figure 6A, bottom panel). The presence of a correct CCA tail
in the artiﬁcially synthesized tRNA
Lys1,2 size þCCA G2 RNA
variant was conﬁrmed by 39-end splint labelling with two
oligonucleotides complementary to the 39 end of G2 RNA
with or without the CCA tail, respectively [28,29] (Figure 6B
and Protocol S1). Taken together these results indicated that
the bulk of the gel-puriﬁed RNAs contained the correct
nucleotide additions. When tested in nuclear import assays,
the original and the variant G2 RNAs lacking the 39 CCA end
had identical RTC import activity; however, addition of the 39
CCA end to the G2 RNA variant resulted in reduced RTC
import activity (Figure 6A).
To gain a better understanding of the structure/function
relationship contributing to the RTC nuclear import activity
of these tRNAs, several deletion and point mutants were
generated using the G2 and G3 clones as template (see
Protocol S1 and Tables S1 and S2). Mutant clones were
generated by PCR, conﬁrmed by sequencing, transcribed in
vitro by T7 RNA polymerase, puriﬁed as before, and
examined in nuclear import assay experiments. Shortening
the acceptor stem had no signiﬁcant effect on the G2 RNA
molecule ability to induce RTC nuclear import (Figure 6C,
panel G2nAS [upper right], and Figure 6D). A deletion
mutant lacking the D-arm (G3 AnC-T) lost some activity, a
deletion mutant containing the D-arm only (G3 D) was almost
completely inactive, and another deletion mutant containing
the T-arm only (G3 T) (minus CCA end) had a dominant
negative activity (Figure 6C, panels G3 AnC-T, G3 D, and G3
T [bottom row], and Figure 6D). The dose-dependent
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tRNAs Promote Nuclear Import of HIV-1Figure 3. The 60S NA Fraction Contains Small RNA Molecules
(A) Equal amounts of nucleic acids purified from the active Phenyl-Sepharose fraction (60S NA) were subjected to nuclease S7 (NS7) or DNAse-free
RNAse (RNAse) treatment and analyzed by 15% denaturing PAGE followed by silver staining. Total HeLa RNA (totRNA) was used as control for nuclease
and RNAse treatments.
ST1, oligonucleotide size markers (range, 8–32 nucleotides); ST2, size markers pBP322DNA-MspI.
(B) 60S NA loses its ability stimulate RTC nuclear import after nuclease or RNAse treatment. Nuclear import of YOYO-1 labelled RTCs in permeabilized
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tRNAs Promote Nuclear Import of HIV-1dominant negative effect of the G3 T mutant was conﬁrmed
in competition assays where more than 70% inhibition of
RTC import was achieved at a 1:1.3 ratio of G3 and mutant
G3 T RNAs (Figure S5). Addition of the full 39 CCA end to the
G3 T mutant resulted in partial loss of the dominant negative
phenotype (Figure S6). The G3 T RNA molecule could not
inhibit M9 nuclear import in the presence of transportin at
the same dose used to completely inhibit RTC nuclear
import, demonstrating substrate speciﬁcity (Figure S5).
Furthermore, disruption of the T-stem secondary structure
by point mutations (G3 C62GþA64C) reduced RTC nuclear
import activity and disruption of the correct T-loop/D-loop
pairing (G3 C56U) had a more severe inhibitory effect (Figure
6C and 6D). These tRNA point mutants have been previously
demonstrated to be as stable as wild-type tRNA [30–32].
Overall these results suggested that correct tRNA folding is
important for RTC nuclear import activity together with the
anticodon loop and the T-arm. The acceptor stem appeared
not to be required, and the 39 CCA end appeared to be
inhibitory in the conditions tested.
Defective tRNAs Accumulate into the Nucleus on Their
Own in an Energy- and Temperature-Dependent Way
We then investigated if these tRNAs species might induce
RTC nuclear import by functioning like adaptors. In vitro
synthesized tRNA molecules were directly labelled with the
nucleic acids dye YOYO-1 after gel puriﬁcation, dialysed, and
tested in the nuclear import assay in the absence of RTCs.
Figure 4. Size Fractionation of the Small RNA Molecules in the 60S NA
(A) The 60S NA was separated onto a 15% denaturing gel, and individual bands were cut, eluted from the gel, and re-loaded onto a 15% denaturing gel
to confirm correct size fractionation. Bands were labelled by SYBR gold staining and visualized by Storm 860 PhosphoImager. ST1 and ST2,
oligonucleotide size markers, as in Figure 3A.
(B) Nuclear import YOYO-1–labelled RTCs in permeabilized HeLa cells in the presence of 13energy-regenerating system and 60S (0.5 mg/ml), 60S NA
(100 ng), the nine main bands eluted from the gel as shown in (A) (140 nM each), or buffer (ctr–).
DOI: 10.1371/journal.pbio.0040332.g004
primary human macrophages in the presence of 13energy-regenerating system and 60S (0.5 mg/ml), 60S NA (1 lg), 60S NA digested with NS7, 60S NA
digested with RNAse (1-lg starting material), 21mer siRNA (1 lg), total HeLa RNA (totRNA, 1lg), or buffer (ctr –).
(C) 60S NA fraction can be specifically 39-end radiolabelled by T4 RNA ligase. Following 39-end labelling with 59-[
32P]pCp, samples were analyzed by 15%
denaturing PAGE and visualized by Storm 860 PhosphoImager. Total HeLa RNA (totRNA) was used as a control for T4 RNA ligase reaction. ST1 and ST2
are 59-end radiolabelled oligonucleotide size markers as in (A).
DOI: 10.1371/journal.pbio.0040332.g003
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tRNAs Promote Nuclear Import of HIV-1Native PAGE showed that the various tRNAs incorporated
YOYO-1 equally well (unpublished data). As shown in Figure
7A, the G3 RNA efﬁciently accumulated into the nucleus only
in the presence of an energy-regenerating system. The G3
C62G point mutant tRNA accumulated less efﬁciently than
G3 tRNA into the nuclei, and the G3 C56U point mutant
tRNA showed almost background levels of nuclear signal,
consistent with data showed in Figure 6D. Wild-type human
tRNA
Lys1,2 and bovine tRNAs were not seen to accumulate
appreciably into the nuclei in an energy-dependent way,
consistent with previous reports [33]. Interestingly, one of the
tRNA species that had very low RTC import activity could still
efﬁciently accumulate into the nuclei on its own (compare
Figure 5B and Figure 7A, B2 RNA), suggesting a speciﬁc
interaction defect with the RTC. The G3 D RNA mutant
remained in the cytoplasm (Figure 7A). These results further
suggested that the T-arm plays an important role in nuclear
accumulation of the tRNAs and that it is likely to be required
for interaction with one or more cellular factors, which may
be part of a nuclear import pathway. They also showed that
nuclear accumulation of these tRNA species is strictly energy
dependent. Moreover, G3 RNA efﬁciently accumulated into
the nuclei only if nuclear import assays were carried out at 37
8C. If assays were carried out at 20 8C, a lower nuclear signal
was observed, and G3 RNA mainly accumulated at the nuclear
periphery. At 0 8C G3 RNA was not found in the nuclei at all
(Figure 7B). Labelled RTCs followed a similar pattern in the
presence of G3 tRNA (Figure 7C). The fact that nuclear
accumulation of these tRNA species was strictly energy and
temperature dependent supports the surprising possibility
that they might be actively imported and did not accumulate
in the nuclei simply by diffusion and selective nuclear
retention [34].
HIV-1 Ability to Infect Non-Dividing Cells and
Incorporation of Active tRNA Species May Depend on gag
All retrovirus particles contain small RNA molecules, most
of which are tRNAs of cellular origin (reviewed in [35]). Thus
we investigated if the tRNAs with RTC nuclear import activity
were also incorporated into HIV-1 particles. Large amounts
of high-titer virus stocks were generated by transfecting 293T
cells and were puriﬁed by two rounds of density sedimenta-
tion in sucrose gradients (see Protocol S1). Analysis by
electron microscopy conﬁrmed the purity of the resulting
samples (unpublished data). Nucleic acids were extracted
from puriﬁed viral samples and analyzed for the presence of
small RNAs. Repeated attempts to distinguish mature cellular
tRNAs from tRNA having a C or CC 39 end by 39-end splint
labelling [29] were unsuccessful, and the high homology of the
two species prevented us from using differential hybrid-
ization. Thus, we took advantage of the fact that some of the
tRNAs lacked the complete 39 CCA end, and we ran samples
onto sequencing gels (Figure 8).
Comparison of the total and small cellular RNA species
with that extracted from puriﬁed HIV-1 virions revealed that
viral-speciﬁc RNAs were enriched in our samples and that
some cellular RNAs were excluded. For example, a band
migrating at approximately 120 nt was clearly visible in viral
samples. but not or barely visible in cellular samples (from
293T cells), even if 20-fold more cellular RNA was loaded on
the gel (Figure 8, compare lanes 1 and 2 with lanes 3 to 6).
Importantly, viral samples contained three distinct bands
migrating at the level of cellular tRNAs. These three bands
were present also in the 60S NA and in fraction 2 and
migrated at a similar level of an artiﬁcially synthesized
tRNA
Lys1,2 having a single 39 C end, or a CC or a full CCA end,
respectively (Figure 8, compare lanes 3 to 6 to lane 9 to lanes
15–17). Incorporation of these small RNA species occurred
independently of the viral genome since they were found also
in virions made in the absence of the vector genome itself
(Figure 8, lanes 5 and 6). The presence of G3 RNA in the
lower migrating band (þC) of the viral preparations was
conﬁrmed by Northern blot (unpublished data).
Recently, the capsid protein (p24 CA) has been shown to be
a crucial determinant for HIV-1 nuclear import, and HIV-1
mutants in which the complete gag region was substituted by
MLV gag were unable to infect non-dividing cells [13]. Thus,
we investigated if such a HIV-1 gag mutant incorporated
tRNA species with RTC nuclear import activity. Wild-type
HIV-1 and the MHIV-mMA12CA mutant containing MLV gag
[13] were concentrated, puriﬁed, and used to infect cells
arrested in the cell cycle by treatment with aphidicolin. In
agreement with a previous study [13], cell cycle arrest
dramatically inhibited MHIV-mMA12CA virus infection
efﬁciency, but had no effect on HIV-1 infection efﬁciency.
RNA was extracted from puriﬁed virus as described earlier
and analyzed by long denaturing PAGE. HIV-1 viruses
contained some tRNA species that migrated differently from
tRNAs present in the mutant MHIV gag virus (Figure 9).
tRNAs were excised from the gel, eluted, and tested in the
nuclear import assay. As shown in Figure 9B, tRNAs eluted
from wild-type HIV-1 induced signiﬁcant RTC nuclear
import, but tRNAs eluted from the MHIV-1 gag mutant were
almost completely inactive. These results suggested that the
MHIV-1 gag mutant virus might not be able to incorporate
and/or interact with tRNA species competent for RTC
nuclear import. Alternatively, tRNAs obtained from the
MHIV-1 gag mutant virus may be unable to interact with
HIV-1 RTCs and conversely the mutant RTCs might not have
the right structure to be actively imported into the nucleus,
despite the presence/incorporation of tRNAs competent for
nuclear import.
Discussion
We have found that some tRNA species promoted nuclear
import of HIV-1 RTCs. Several lines of evidence support
these conclusions. First, small RNAs isolated by chromatog-
raphy from cytosolic extracts induced nuclear import of
RTCs, and RNAse treatment of the samples eliminated
import activity. Second, only one species of small RNAs had
nuclear import activity following size fractionation of the
active sample in denaturing gels, thus excluding a non-
speciﬁc effect due to the presence of small RNA molecules in
the import assay. Third, the same RNA molecules synthesized
in vitro were active, and import activity could be mapped to
the anticodon and T-arm regions. Importantly, the structural
requirements were the same for nuclear import of RTCs and
nuclear accumulation of the tRNAs on their own, making it
unlikely that tRNAs were simply titrating out an inhibitor of
RTC nuclear import. Lastly, tRNA species with HIV-1 RTC
nuclear import activity were incorporated into and recovered
from HIV-1 viral particles.
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tRNAs Promote Nuclear Import of HIV-1It is not completely clear at present how these tRNAs
species may promote nuclear import of HIV-1 RTCs; none-
theless, some insight may be gained from the available data.
The in vitro synthesized tRNAs efﬁciently accumulated into
the nuclei of permeabilized cells in a strictly energy- and
temperature-dependent way. A very similar temperature
dependence was observed for tRNA nuclear export and is
consistent with a carrier-mediated translocation mechanism
[36]. Moreover, these tRNA species promoted nuclear import
of the RTC, a complex too large to diffuse through nuclear
pore complexes. Hence it is unlikely that tRNA accumulate in
the nuclei by passive diffusion and selective nuclear reten-
tion. Overall, our results support the surprising possibility
that at least some tRNA species may be actively uptaken into
the nucleus of human cells. We note that both normal and
CCA-less tRNAs have recently been reported to actively
shuttle between nucleus and cytoplasm in yeast cells [37,38].
In our experimental conditions, RTC and tRNA nuclear
accumulation was also reliant on structural features because
point mutant tRNA molecules, in which the correct T-stem
folding was disrupted, were found in the nuclei at reduced
levels and had low RTC import activity. Furthermore, a
minihelix made of the T-arm only had dominant negative
activity. It is conceivable that the properly folded T-arm
interacts with putative cellular factors important for nuclear
import of the tRNAs whereas the anticodon arm may be more
important for interaction with the RTC. This is supported by
the fact that the highly homologous B1, B2, and B3 tRNAs
were inactive in inducing RTC nuclear import, but B2 tRNA
could still be efﬁciently imported into the nucleus on its own,
suggesting a defect in RTC binding. On the other hand, B4
tRNA was clearly active in stimulating RTC nuclear import
and differed from B1, B2, and B3 tRNAs in the anticodon
loop. However, the anticodon itself is not sufﬁcient to confer
speciﬁc RTC binding since at least some tRNA
Gly, tRNA
Glu,
and tRNA
Lys1,2 had RTC nuclear import ability. The very low
nuclear import of MLV RTCs induced by G3 tRNA also
suggests that speciﬁc interactions are required between some
tRNAs and their RTC substrate.
In light of these observations, the simplest model to explain
tRNA-mediated nuclear import of RTCs is based on multiple
interactions between the anticodon arm and the viral
complex on one hand and the T-arm and putative cellular
factors promoting nuclear import on the other hand.
Interestingly, the T-arm is also important in tRNA nuclear
export since the same mutations in the T-stem-loop that we
have tested also abolish interaction with exportin-t [31,32].
Moreover, the fact that the T-stem secondary structure
requirements for RTC and tRNAs nuclear accumulation were
the same argue against the possibility that these defective
tRNAs titrate out an inhibitor of import.
tRNA maturation is a multistep process that, in vertebrates,
takes place in the nucleus, and mature tRNAs are then
exported into the cytoplasm [39,40]. Export of tRNA by
exportin-t, for example, requires the tRNA to be fully
processed, providing a means to proofread tRNAs before
they leave the nucleus [31,32,41]. Therefore it is not obvious
why some tRNA species should be actively re-uptaken into
the nucleus in human cells. One possibility could be that,
given their relatively long half-life, some mature tRNAs are
damaged in the cytoplasm by nucleases that remove one or
more nucleotides from the 39 CCA end. The resulting tRNAs
cannot be aminoacylated, but may interfere with protein
translation. This would then require the rapid removal of the
defective tRNAs either by repairing the 39 CCA end in the
cytoplasm or by sequestering them into the nucleus where
they might be repaired or degraded. There is evidence in
yeast cells that tRNAs lacking the 39 CCA end do accumulate
and cause a growth defect if repairing enzymes are depleted
from the cytosol [42]. Thus, nuclear re-uptake of tRNAs with a
defective CCA end would provide a quality control system in
addition to nuclear export. An alternative way to explain
preferential accumulation into the nucleus of tRNAs lacking
the full 39 CCA end might be that mature tRNAs are quickly
imported and then re-exported in the cytoplasm in our assay.
Moreover, in permeabilized cells, mature tRNAs may bind to
cellular factors, which may retain them in the cytoplasm,
making them unsuitable substrates for nuclear import.
Interestingly, the G3 T mutant with a 39 CCA end lost most
of its dominant negative phenotype, suggesting that it might
be sequestered by cellular factors different from those
involved in nuclear import. Thus, on the basis of the present
data, we cannot exclude that mature tRNAs are also actively
imported into the nucleus of human cells. Future work will
address this important aspect.
It is long recognized that cellular tRNAs are packaged into
retroviral particles with a stoichiometry of 20 or more
molecules per virion [35] and that some of them have
defective 39 ends [43]. About 10% of these tRNAs bind tightly
to the viral genome and serve as primers for reverse
transcription, but the role of the other, less tightly bound
tRNAs is unknown. Remarkably, in several cases, virus
incorporation of tRNAs is selective. For example, avian
retroviruses preferentially package tRNA
Trp, and MLV pack-
Figure 5. Nuclear Import Activity of Small RNA Molecules Generated In Vitro
(A) Nuclear import of YOYO-1–labelled RTCs in permeabilized HeLa cells in the presence of 13 energy-regenerating system and Fr2 (100 ng), the
indicated small RNAs generated by in vitro T7 transcription (see Table 1, Protocol S1, and Table S2) (140 nM each, corresponding to ;100 ng), human
tRNA
Lys1,2 (100 ng), bovine tRNAs (100 ng), or buffer (ctr–). Nuclear import of the G3 RNA molecule in the absence of YOYO-1–labelled RTCs (G3 RTC)
was used as an additional negative control.
(B) Quantification of RTC nuclear import as shown in (A). Images acquired by confocal microscopy were analyzed by MetaMorph software version 4.5r4
(Universal Imaging Corp) and the total fluorescence of the nuclei divided by the number of cells per field (see also Figure S2). At least 150 cells were
counted per experiment. Bars represent the log mean fluorescence per nucleus 6 standard deviation of six independent experiments.
(C) Quantification of G2/G3 RNA in HSE NA and 60S NA by Northern blot. RNA was separated by 15% denaturing PAGE, transferred onto a nylon
membrane, and probed with an oligonucleotide complementary to G2/G3 RNA. There were 100-ng G3 RNA (lane 1), 10-ng G3 RNA (lane 2), 100-ng
negative control A9 RNA (tRNA
Gly) (lane 3), 700-ng HSE NA (lane 4), 350-ng HSE NA (lane 5), 175-ng HSE NA (lane 6), and 200-ng 60S NA (lane 7). Upper
panel, hybridized membrane visualized by Phosphoimager, lower panel, SYBR Gold staining of denaturing PAGE. Image Quant (Molecular Dynamics)
was used to calculate the intensity of the signals.
(D) Comparative RTC nuclear import activity of HSE NA (100 ng), 60S NA (100 ng), G3 RNA (100 ng), G3 RNA (10 ngþ90-ng carrier siRNA), buffer (ctr–), or
bufferþ100-ng carrier RNA. Nuclear import assays were performed in permeabilized HeLa cells in the presence of labelled RTCs, 13energy mix, and the
indicated RNAs. Bars represent the fold nuclear import increase above background (RTC þ energy mix) 6 standard deviation of two independent
experiments.
DOI: 10.1371/journal.pbio.0040332.g005
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Pro and all lentiviruses in addition to mouse
mammary tumour virus (MMTV), Foamy viruses (FV) and
Mason-Pﬁzer monkey virus preferentially package tRNA
Lys
[43–49]. tRNA incorporation into viral particles is mainly
mediated by gag and reverse transcriptase, which is important
for speciﬁc tRNA selection [50–52]. Our data suggest that
some of these tRNA species may be important for nuclear
import of retroviral genomes. Such tRNA species, by binding
to the viral complex either before budding or perhaps after
entry into the cell, may act as adaptors and allow RTC
engagement with the cellular nuclear import machinery
following virus uncoating [13,53].
Our results point to the existence of two or more cellular
pathways mediating RTC nuclear import, one dependent on
imp7 and another dependent on tRNAs. In this respect it may
be relevant that nuclear export of mRNA and tRNA is also
mediated by multiple and often redundant factors [40,54,55].
It will be interesting to investigate in more detail the
interactions between these two pathways and whether cells
with a low metabolism (like resting CD4
þ memory T cells and
resident macrophages) also accumulate defective tRNA
species similar to starved yeast cells [56] and preferentially
use the tRNA pathway for HIV-1 nuclear import.
Materials and Methods
Cell culture, recombinant virus production, and RTC puriﬁcation.
HeLa and 293T cells were grown in Dulbecco’s modiﬁed Eagle’s
Medium (DMEM) with Glutamax (GIBCO Labs, Paisley, United
Kingdom) supplemented with 10% foetal calf serum (FCS) (Helena
Bioscience, Newcastle, United Kingdom), SupT1 and Jurkat cells were
grown in RPMI 1640 media (GIBCO) supplemented with 10% FCS at
37 8C in a humidiﬁed atmosphere containing 5% CO2. Human
primary monocytes were isolated and grown as described previously
[14]. HIV-1 vectors were made and puriﬁed as described previously
[57] using plasmids pCSGW, expressing GFP; pCMVDR8.2, expressing
Figure 6. Structural Requirements of tRNAs for RTC Nuclear Import
Activity
(A) Quantification of RTC nuclear import in the presence of G2 RNA,
modified G2 RNA, and modified G2 RNA with 39 CCA end. Quantification
was performed as in (D) and bars represent the mean log fluorescence
value of the nuclei 6 standard deviation of five independent experi-
ments. Correct generation of the tRNA
Lys1,2-size G2 RNA and addition of
the CCA tail to this RNA was monitored by long 15% denaturing PAGE
followed by SYBR Gold staining (bottom panel).
(B) The presence of the correct 39 CCA tail in the tRNA
Lys1,2 þ CCA
molecule was monitored by splint labelling. The tRNA
Lys1,2 þ CCA RNA
was purified by denaturing PAGE as shown in (A), bottom. Following
splint labelling with [a-
32P]dATP, the G2þCCA RNA was re-analyzed on a
15% denaturing PAGE and visualized by PhosphoImager (see Protocol
S1). Labelling was performed with antisense primer  CCA (lane 1), and
with antisense primer þCCA (lane 2).
(C) Nuclear import of YOYO-1–labelled RTC in permeabilized HeLa cells in
the presence of 13 energy-regenerating system and mutant RNAs
generated by in vitro T7 transcription (140 nM each) (see Tables S1 and
S2) or buffer (ctr–).
G2, original RNA; G2nAS, mutant with shortened acceptor stem; G3,
original RNA; G3 C56U, point mutation disrupting D- and T-loops pairing;
G3 C62G þ A64C, double point mutation disrupting T-stem secondary
structure; G3 AnC-T, deletion mutant lacking the D-arm; G3D, deletion
mutant lacking anticodon loop and T-arm; G3T, deletion mutant lacking
D- and anticodon arms.
(D) Quantification of RTC nuclear import with the same RNA mutants as
shown in (C). Images were acquired by confocal microscopy and
analyzed using the MetaMorph software version 4.5r4 (Universal Imaging
Corp) and the total fluorescence in the nucleus divided by the number of
cells per field. At least 150 cells were counted per experiment. Bars
represent the percentage of total fluorescence per nucleus relative to
control (G2 and G3 ¼ 100) 6 standard deviation of three independent
experiments.
DOI: 10.1371/journal.pbio.0040332.g006
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tRNAs Promote Nuclear Import of HIV-1Figure 7. In Vitro Generated tRNAs Accumulate into the Nucleus of Permeabilized HeLa Cells in an Energy- and Temperature-Dependent Way
(A) Nuclear import assay in permeabilized HeLa cells in the presence or absence of 13energy-regenerating system and YOYO-1–labelled RNA molecules
and their mutants (see Tables S1 and S2 and Figure 6) (140 nM each, corresponding to 100 ng), human tRNA
Lys1,2 (100 ng), and bovine tRNAs (100 ng).
Nuclear import assay of the G3 D mutant RNA was performed in the presence of 100 ng inactive carrier RNA (21mer RNA)
(B) Nuclear import assay in the presence of 140 nM YOYO-1–labelled G3 RNA performed at different temperatures with or without an energy-
regenerating system.
(C) Nuclear import assay with labelled RTCs and buffer (RTC) or 140 nM G3 RNA (RTCþG3) performed at different temperatures in the presence of an
energy-regenerating system.
DOI: 10.1371/journal.pbio.0040332.g007
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tRNAs Promote Nuclear Import of HIV-1viral core proteins, and pMD.G, expressing VSV-G [58,59]. Moloney
MLV was made using plasmid pCNCG, pGP NB, and pMD.G [60]. The
MHIV-1 gag mutant was made using plasmid MHIV-mMA12CA-
delEnv-luc and pHR9 (pMD.G was also used for infection experi-
ments) [13]. RTCs were puriﬁed from acutely infected HeLa cells or
293T cells (for MLV) and labelled with YOYO-1 as previously
described [14]. Cells (6 3 10
4 well/24-well plates) were arrested in
G1/S by treatment with 1.5-lg/ml aphidicolin (Sigma, St. Louis,
Missouri, United States) for 24 h in complete media, infected, and
analyzed by ﬂow cytometry 24 h after infection.
Preparation and initial fractionation of HSEs. HSEs were prepared
from HeLa, SupT1, and Jurkat cells as previously described [20].
Further fractionation was achieved by stepwise precipitation with
saturated AS to ﬁnal concentrations of 15%, 30%, 45%, and 60%.
After addition of AS, samples were stirred at 4 8C for 1–2 h,
centrifuged for 20 min at 6,0003g at 4 8C, and supernatants were used
in the next round of precipitation. Pellets and supernatants were re-
suspended in import buffer (20 mM HEPES-KOH [pH 7.3], 110 mM
potassium acetate, 5 mM magnesium acetate, 0.5 mM EGTA) and
dialyzed overnight against multiple changes of the same buffer.
Fractions were normalized for protein concentration, tested in the
nuclear import assay, and analyzed by SDS-PAGE. The 60P was
depleted of importins by addition of 3 mM ﬁnal b-mercaptoethanol
and loading the sample onto a 1-ml low-substitution Phenyl-
Sepharose column (Amersham, Little Chalfont, United Kingdom)
equilibrated with import buffer supplemented with 250 mM sucrose
and 3 mM b-mercaptoethanol at a ﬂow rate 0.15 ml/min. The ﬂow-
through fraction was depleted 60P.
Isolation of the active fraction from HSE. The active fraction was
isolated from HSE in the following steps. A saturated solution of AS
was added to HSE to a ﬁnal concentration of 60%. The sample was
stirred at 4 8C for 1–2 h and centrifuged for 20 min at 6,0003g. The
60S was collected and applied to a 5-ml high-substitution Phenyl-
Sepharose column (Amersham) equilibrated with buffer HDM (50
mM HEPES [pH 7.3], 1 mM DTT, 1 mM EDTA) þ 60% AS at a ﬂow
rate of 1 ml/min. The column was washed with 25 ml of HDMþ 60%
AS and eluted with 25 ml of 60% to 0% AS gradient in HDM. Peak
fractions (280 nm) were collected and dialyzed overnight against 5 l of
20 mM HEPES (pH 7.3) buffer and concentrated by centrifugation in
Centricon YM-3 (Millipore, Billerica, Massachusetts, United States).
Samples were further fractionated in a Mono Q PC 1.6/5 column
(Amersham) equilibrated in buffer A (20 mM Tris-HCl [pH 7.6]) at a
ﬂow rate of 1 ml/min. The column was washed with ﬁve column
volumes of buffer A and eluted with 15 column volumes of a 0 to 1 M
NaCl linear gradient in buffer A. Fractions (0.1 ml) were collected,
and peak fractions pooled, dialyzed overnight against 4 L of import
buffer, and concentrated by centrifugation in Centricon YM-3. After
normalization for protein concentration, fractions were tested in the
nuclear import assay and analyzed by SDS-PAGE. To obtain the 60S
NA, the concentrated active fraction after chromatography on
Phenyl-Sepharose column (from HeLa, SupT1, and Jurkat cells) was
treated with Proteinase K (10 lg/ml) at 37 8C, 30 min, and nucleic
acids were extracted by phenol/chloroform and ethanol-precipitated.
39-end labelling by T4 RNA ligase. 60S NA, total RNA from HeLa
cells, and 21mer siRNA were dephosphorylated (90-ll reaction, 37 8C,
30 min, 45-U Shrimp Alkaline Phosphatase [Roche, Basel, Switzer-
land]). The reaction was stopped by phenol/chloroform extraction,
and ethanol-precipitated RNA was then 39-end radiolabelled (10-ll
reaction, 37 8C, 30 min, 20 mM Tris-HCl [pH 7.8], 10 mM MgCl2,1 0
mM DTT, 1 mM ATP, 15% DMSO, 26-U T4 RNA ligase [New England
Biolabs, Beverly, Massachusetts, United States], 10-lCi 59-[
32P]pCp).
The reaction was stopped by addition of an equal volume of StopMix
(8 M urea/50 mM EDTA) and directly loaded onto a 15% denaturing
PAGE. 59-end radiolabelled (by standard procedure recommended
for T4 polynucleotide kinase) pBP322DNA-MspI (New England
Biolabs) and oligonucleotide sizing markers (range, 8–32 bases)
(Amersham) were used as standards. After electrophoresis, the gel
was dried and visualised by Storm 860 PhosphoImager (Molecular
Dynamics, Sunnyvale, California, United States).
Size fractionation of 60S NA and isolation of fraction 2. The 60S
NA was separated by 15% denaturing PAGE and visualized by
ethidium bromide (Sigma) or SYBR Gold (Molecular Probes, Eugene,
Oregon, United States) staining according to the manufacturer’s
instructions. Nine bands of different sizes were excised from the gel
and eluted overnight at 4 8C into 0.53 TBE, 0.3 M NaCl buffer. The
RNA was recovered by ethanol precipitation in the presence of 20-lg/
ml glycogen (Roche). All samples were re-suspended in RNAse-free
import buffer, normalized for RNA concentration, and tested in the
nuclear import assay.
Cloning of the small RNA molecules. The small RNAs contained in
fraction 2 (Fr2) were cloned using a method modiﬁed from Elbashir
et al. [22]. A total of 5 lg of Fr2 was dephosphorylated (130-ll
reaction, 37 8C, 30 min, 75-U Shrimp Alkaline Phosphatase [Roche]).
The reaction was stopped by phenol/chloroform extraction, and RNA
was ethanol precipitated. The 39 adaptor oligonucleotide
(pUUUaaccgcatccttctcx: where uppercase indicates RNA, lowercase
indicates DNA, p represents phosphate, and x represents 4-
hydroxymethylbenzyl) (Dharmacon, Lafayette, Colorado, United
States) was ligated to 1 lg of dephosphorylated Fr2 (15-ll reaction,
37 8C, 30 min, 5 lM3 9 adapter, 50 mM Tris-HCl [pH 7.6], 10 mM
MgCl2, 0.2 mM ATP, 0.1-mg/ml acetylated BSA, 15% DMSO, 25-U T4
RNA ligase [Amersham]). The ligation reaction was stopped by
addition of an equal volume of StopMix and directly loaded onto a
long (24 cm) 15% denaturing PAGE. pBP322DNA-MspI (New England
Biolabs) and oligonucleotide sizing markers (range, 8–32 bases)
(Amersham) were used as a size standard. After electrophoresis, the
gel was stained with SYBR Gold (Molecular Probes). Ligation
efﬁciency was approximately 50%. The ligation product was
recovered from the gel and concentrated by ethanol precipitation.
The ligation product was mixed with 100 pM 39 RT primer
(GACTAGCTGGAATTCAAGGATGCGGTTAAA) and heated 2 min
at 90 8C. Reverse transcription (20-ll reaction, 42 8C, 1 h followed by
70 8C, 15 min, 200-U SuperScript II RNaseH
  reverse transcriptase
(Invitrogen, Carlsbad, California, United States) in recommended
buffer) was followed by RNAse H (Invitrogen) treatment. Synthesis of
the ﬁrst cDNA strand was monitored by a parallel RT reaction in the
presence of [
32P] dCTP. A poly C tail was added to the 39 end of the
ﬁrst cDNA strand (20 ll reaction, 37 8C, 15 min, 25-U terminal
transferase [New England Biolabs]), and the reaction stopped by heat
inactivation at 75 8C, 10 min. Formation of the poly C tail was
monitored by a parallel terminal transferase reaction in the presence
of Cy5-dCTP. The terminal transferase product was PCR ampliﬁed
(with Pfu Taq polymerase) using RACE-G primer (GACCACGCG-
TATCGATGTCGAGGGGGGGGGGGGGGGG (A, C, and T)) and the
39 RT primer. The PCR products were gel puriﬁed by 7.5% non-
denaturing PAGE, eluted, and ethanol precipitated. The PCR
products were then directly ligated into pCR2.1-TOPO vector using
TOPO TA cloning kit (Invitrogen). Colonies were screened by PCR
and directly used for custom sequencing.
Nuclear import assay. Cells, approximately 50% conﬂuent in
gelatin-coated 5-mm diameter microdishes (MaTek Corp., Ashland,
Massachusetts, United States), were washed in import buffer and
permeabilized for 5 min on ice in import buffer containing 40-lg/ml
digitonin (Fluka, Buchs, Switzerland). After two washes in import
buffer, samples were incubated for 15 min at 37 8C in a tissue culture
incubator in the presence of approximately 10
3 labelled RTCs/cell,
recombinant imp7 or small RNAs (concentrations indicated in ﬁgure
legends), and an energy-regenerating system (1 mM ATP, 1 mM GTP,
20 mM creatine phosphate, 40-U/ml creatine phosphokinase) in 30-ll
ﬁnal volume. Samples were washed in import buffer, ﬁxed on ice for 5
min with 2% paraformaldehyde in import buffer, and analyzed
directly by confocal microscopy. Images acquired by confocal
microscopy were analyzed by MetaMorph software version 4.5r4
(Universal Imaging Corp, Molecular Devices, Wokingham, United
Figure 8. Profile of Small RNA Species Incorporated into HIV-1 Particles
Total and small RNA were obtained from cells and purified virions, and analyzed onto a long (50 cm) 15% denaturing PAGE followed by SYBR Gold
staining. There was a 10-bp DNA ladder (lane St), 2.3-lg total 293T RNA (lane 1), 1.5-lg small 293T RNA (lane 2), purified HIV-1 virion RNA (169 ng and
338 ng) (lanes 3 and 4, respectively), purified RNA from HIV-1 virions not containing the viral genome (472 ng and 236 ng) (lanes 5 and 6, respectively),
2.7-lg total HeLa RNA (lane 7), 2.4-lg small HeLa RNA (lane 8), 100-ng 60S NA fraction from HeLa cells (lane 9), 100-ng Fr2 from HeLa cells (lane 10), 0.9-
lg SupT1 small RNA (lane 11), 200-ng 60S NA fraction from SupT1 cells (lane 12), 200-ng Fr2 from SupT1 cells (lane 13), 1.5-lg bovine tRNA (lane 14),
200-ng tRNA
Lys1,2 size G2 RNAþC tail (see Table S2) (lane 15), 200-ng tRNA
Lys1,2 size G2 RNAþCC tail (lane 16), and 200-ng tRNA
Lys1,2 size G2 RNAþCCA
tail (lane 17). Asterisks indicate positions of similar size bands in different lanes. Arrows indicate small RNAs specifically enriched in purified virions. The
contrast in lanes 3 to 6 in the magnified rectangle has been artificially increased to help in visualizing bands.
DOI: 10.1371/journal.pbio.0040332.g008
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tRNAs Promote Nuclear Import of HIV-1Figure 9. MHIV-1 gag Mutant Does Not Incorporate tRNA Species with RTC Nuclear Import Activity
(A) Viral RNA (1.5 lg) was extracted from purified HIV-1 (lane 1) or MHIV-1 gag mutant (lane 2) and separated onto a long (50 cm) 15 % denaturing PAGE
followed by SYBR Gold staining. There was a 10-bp DNA ladder (lane St), 25-ng tRNA
Lys1,2 size G2 RNAþC tail (see Table S2) (lane 3), 25-ng tRNA
Lys1,2
size G2 RNAþCC tail (lane 4), and 25-ng tRNA
Lys1,2 size G2 RNAþCCA tail (lane 5). Asterisks indicate the three small RNA bands found in HIV-1; arrows
indicate viral-specific small RNA molecule common to both viruses.
(B) Single-cycle infection assays in cell cycle–arrested cells. Cells were treated with aphidicolin for 24 h to induce G1/S arrest, infected with the same
dose of wild-type HIV-1 or MHIV gag mutant, and analyzed for GFP expression by flow cytometry 24 h after infection. Bars represent the average value
6 standard deviation of two experiments.
(C) Nuclear import of YOYO-1–labelled HIV-1 RTCs in permeabilized HeLa cells in the presence of 13 energy-regenerating system and buffer (ctr–) or
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tRNAs Promote Nuclear Import of HIV-1Kingdom) for quantiﬁcation. Thresholding was performed to deﬁne
areas to be analyzed. The threshold value was set so that no objects
were visible in negative control samples. Integrated morphometric
analysis (total grey value) was performed on the visible objects in the
test samples, and the total grey value divided by the number of nuclei
per ﬁeld (Figure S2).
Supporting Information
Figure S1. 60S NA Puriﬁed from Jurkat and SupT1 T-Lymphocytic
Cell Lines Stimulate RTC Nuclear Import
(A) 15% denaturing PAGE of the 60S NA puriﬁed from the
indicated cell lines followed by SYBR Gold staining (200 ng/lane). (B)
Nuclear import of YOYO-1–labelled RTCs in permeabilized HeLa
cells in the presence of 13 energy-regenerating system and 60S NA
from the indicated cell line (100 ng) or buffer (ctr  ). Scale bar
indicates 25 lm.
Found at DOI: 10.1371/journal.pbio.0040332.sg001 (3.1 MB TIF).
Figure S2. MetaMorph Image Analysis for Quantiﬁcation of RTC
Nuclear Import
Nuclear import was performed in permeabilized HeLa cells in the
presence of ﬂuorescent-labelled RTCs, 13 energy mix and buffer
(ctr ) or 140-nm G3 RNA (test). Samples were ﬁxed, then images were
acquired by confocal microscopy and processed by Metamorph
software version 4.5r4. The threshold signal of the starting image is
adjusted to select all objects of interest (overlaid red cells) in both
control and test samples (thresholding). Next, the image is ‘‘seg-
mented’’ so that areas in which the pixel intensities are above the
threshold range (red nucleoli and nuclear envelope) will be marked in
the image (segmenting). Finally, the software integrates the signal
from the areas shown in the segmentation images only (now shown in
bright green and present mainly in the nucleoli) and gives the total
grey value. This value is divided by the total number of nuclei in the
ﬁeld to give the ﬁnal reading. Because only the bright green signal is
integrated, the background cytoplasmic signal (darker green) is not
included in the total grey value.
Found at DOI: 10.1371/journal.pbio.0040332.sg002 (6.6 MB TIF).
Figure S3. FISH Analysis following the Nuclear Import Assay
FISH was performed with an RTC-speciﬁc probe following nuclear
import in permeabilized HeLa cells in the presence of 13 energy-
regenerating system (RTCþE) and 140 nM G3 RNA (RTCþEþG3) or
140 nM B2 RNA (RTC þ E þ B2). Control experiments in the absence
of RTCs (CTR ) were performed to test the speciﬁcity of the probe
and samples were analyzed by confocal microscopy. Scale bar indicates
12 lm.
Found at DOI: 10.1371/journal.pbio.0040332.sg003 (2.7 MB TIF).
Figure S4. The G3 RNA Does Not Promote Nuclear Import of MLV
RTCs
Nuclear import assay in permeabilized HeLa cells in the presence of
13 energy mix, approximately 10
5 MLV or HIV-1 RTCs/assay and
buffer (buffer) or 280 nM G3 (G3) or B2 RNAs (B2). Images were
acquired by confocal microscopy using the same settings.
Found at DOI: 10.1371/journal.pbio.0040332.sg004 (2.5 MB TIF).
Figure S5. 60S NA, Fraction 2, G3 RNA, and G3 T RNA Molecules Do
Not Affect Nuclear Import of Maltose Binding Protein Fused to the
M9 Peptide (M9)
(A) Nuclear import assays were performed in permeabilized HeLa
cells in the presence of 13 energy mix, 1 lM ﬂuorescent-labelled M9
and 1 lM transportin (M9þTR) or 100 ng 60S NA (M9þ60S NA), 100
ng fraction 2 (M9 þ Fr2), 140nM (corresponding to 100 ng) G3 RNA
(M9þG3), 140 nM B2 RNA (M9þB2), 672 nM G3-T RNA (M9þG3T),
672 nM G3-T RNA, and 1 lM transportin (M9 þ TR þ G3 T). (B)
Nuclear import assays were performed in parallel with experiments
shown in (A) in the presence of labelled RTCs and buffer (ctr ) or 140
nM G3 RNA. Note that the settings of the confocal microscope were
different between (A) and (B) because M9 produced a stronger
ﬂuorescence signal than RTCs.
Found at DOI: 10.1371/journal.pbio.0040332.sg005 (956 KB TIF).
Figure S6. G3 T RNA, Lacking the D- and Anticodon Arms, Is a
Dominant Negative Mutant
(A) Quantiﬁcation of RTC accumulation in HeLa nuclei following the
import assay in the presence of 13 energy-regenerating system, 140
nM G3 RNA, and the mutant G3T RNA (with 39 C end) at the
concentrations indicated. Bars represent mean ﬂuorescent value 6
standard deviation of three independent experiments. (B) Same as
(A), but the assay was performed in the presence of G3 T (ﬁlled
triangles) and G3T þ 39 CCA end (empty triangles). Data are
representative of two independent experiments. Images were
acquired by confocal microscopy and analyzed by MetaMorph
software version 4.5r4. Samples were threshold at the same values
and the total ﬂuorescence divided by the number of cells per ﬁeld.
Samples containing RTC þ buffer were given an arbitrary value of
100%. At least 150 cells were counted per experiment.
Found at DOI: 10.1371/journal.pbio.0040332.sg006 (1.0 MB TIF).
Protocol S1. Supplementary Materials and Methods
Found at DOI: 10.1371/journal.pbio.0040332.sd001 (33 KB DOC).
Table S1. Mutagenesis of Clones Contained in Fraction 2
Found at DOI: 10.1371/journal.pbio.0040332.st001 (38 KB DOC).
Table S2. Primers Used for Generation of the T7 RNA-Polymerase
Templates
Found at DOI: 10.1371/journal.pbio.0040332.st002 (55 KB DOC).
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